• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞蛋白质对顺铂加合物的识别。

Recognition of cisplatin adducts by cellular proteins.

作者信息

Kartalou M, Essigmann J M

机构信息

Department of Chemistry, Division of Bioengineering and Environmental Health, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Mutat Res. 2001 Jul 1;478(1-2):1-21. doi: 10.1016/s0027-5107(01)00142-7.

DOI:10.1016/s0027-5107(01)00142-7
PMID:11406166
Abstract

Cisplatin is a widely used chemotherapeutic agent. It reacts with nucleophilic bases in DNA and forms 1,2-d(ApG), 1,2-d(GpG) and 1,3-d(GpTpG) intrastrand crosslinks, interstrand crosslinks and monofunctional adducts. The presence of these adducts in DNA is through to be responsible for the therapeutic efficacy of cisplatin. The exact signal transduction pathway that leads to cell cycle arrest and cell death following treatment with the drug is not known but cell death is believed to be mediated by the recognition of the adducts by cellular proteins. Here we describe the structural information available for cisplatin and related platinum adducts, the interactions of the adducts with cellular proteins and the implications of these interactions for cell survival.

摘要

顺铂是一种广泛使用的化疗药物。它与DNA中的亲核碱基发生反应,形成1,2 - d(ApG)、1,2 - d(GpG)和1,3 - d(GpTpG)链内交联、链间交联和单功能加合物。DNA中这些加合物的存在被认为是顺铂治疗效果的原因。在用该药物治疗后导致细胞周期停滞和细胞死亡的确切信号转导途径尚不清楚,但细胞死亡被认为是由细胞蛋白识别加合物介导的。在这里,我们描述了可获得的顺铂及相关铂加合物的结构信息、加合物与细胞蛋白的相互作用以及这些相互作用对细胞存活的影响。

相似文献

1
Recognition of cisplatin adducts by cellular proteins.细胞蛋白质对顺铂加合物的识别。
Mutat Res. 2001 Jul 1;478(1-2):1-21. doi: 10.1016/s0027-5107(01)00142-7.
2
Recognition and repair of DNA-cisplatin adducts.DNA-顺铂加合物的识别与修复。
Acta Biochim Pol. 2002;49(3):583-96.
3
Cisplatin.顺铂
Essays Biochem. 1999;34:191-211. doi: 10.1042/bse0340191.
4
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.高迁移率族蛋白识别顺铂修饰DNA的基础。
Nature. 1999 Jun 17;399(6737):708-12. doi: 10.1038/21460.
5
Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.顺铂 - DNA加合物抑制DNA依赖蛋白激酶(DNA-PK)的Ku亚基的易位。
Nucleic Acids Res. 2000 Dec 1;28(23):4634-41. doi: 10.1093/nar/28.23.4634.
6
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.哺乳动物切除核酸酶对顺铂-DNA加合物的修复
Biochemistry. 1996 Aug 6;35(31):10004-13. doi: 10.1021/bi960453+.
7
Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.含有抗癌药物顺铂主要加合物的双链DNA的晶体结构。
Nature. 1995 Oct 19;377(6550):649-52. doi: 10.1038/377649a0.
8
DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.抗肿瘤反式-[PtCl2(NH3)(噻唑)]与DNA的结合。单功能加合物的蛋白质识别与核苷酸切除修复。
Biochemistry. 2003 Jan 28;42(3):792-800. doi: 10.1021/bi026614t.
9
Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.含有由抗肿瘤双核铂配合物形成的位点特异性d(GpG)链内交联的双链DNA的热力学性质。
Nucleic Acids Res. 2001 May 15;29(10):2034-40. doi: 10.1093/nar/29.10.2034.
10
Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.在反式铂中用亚胺醚取代氨会使一种无活性的化合物变成一种抗肿瘤药物。
Mol Pharmacol. 2000 Dec;58(6):1525-35. doi: 10.1124/mol.58.6.1525.

引用本文的文献

1
Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors.范可尼贫血综合综述:对DNA链间交联、修复途径及相关肿瘤的见解
Orphanet J Rare Dis. 2025 Jul 30;20(1):389. doi: 10.1186/s13023-025-03896-w.
2
Genetic signatures of and expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy.与单核苷酸多态性(SNPs)变异一起,[具体基因名称1]和[具体基因名称2]表达的遗传特征揭示了接受铂类化疗的小细胞肺癌(SCLC)患者的良好预后。 (注:原文中“and expression”前缺少具体基因名称,这里用[具体基因名称1]和[具体基因名称2]代替以便完整表意)
Oncol Res. 2024 Dec 20;33(1):45-55. doi: 10.32604/or.2024.050161. eCollection 2025.
3
DEWNA: dynamic entropy weight network analysis and its application to the DNA-binding proteome in A549 cells with cisplatin-induced damage.
德瓦纳:动态熵权网络分析及其在顺铂诱导损伤的 A549 细胞 DNA 结合蛋白质组中的应用。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae564.
4
Metal-Organic Frameworks for Cisplatin Delivery to Cancer Cells: A Molecular Dynamics Simulation.用于顺铂递送至癌细胞的金属有机框架:分子动力学模拟
ACS Omega. 2024 Apr 22;9(17):19627-19636. doi: 10.1021/acsomega.4c01437. eCollection 2024 Apr 30.
5
Nucleic Acid-based Electrochemical Sensors Facilitate the Study of DNA Binding by Platinum (II)-based Antineoplastics.基于核酸的电化学生物传感器有助于研究基于铂(II)的抗肿瘤药物与 DNA 的结合。
Angew Chem Int Ed Engl. 2024 Mar 18;63(12):e202312402. doi: 10.1002/anie.202312402. Epub 2024 Feb 16.
6
Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer.非编码RNA在肺癌对铂类抗癌药物耐药中的新作用
Front Pharmacol. 2023 Jan 26;14:1105484. doi: 10.3389/fphar.2023.1105484. eCollection 2023.
7
Cytotoxic sub-nanometer aqueous platinum clusters as potential antitumoral agents.细胞毒性亚纳米级水性铂簇作为潜在的抗肿瘤药物。
Nanoscale Adv. 2022 Oct 10;4(24):5281-5289. doi: 10.1039/d2na00550f. eCollection 2022 Dec 6.
8
Structural Characterization of Cis- and Trans-Pt(NH)Cl Conjugations with Chitosan Nanoparticles.顺铂和反式铂(NH)Cl 与壳聚糖纳米粒子的缀合物的结构特征。
Molecules. 2022 Sep 23;27(19):6264. doi: 10.3390/molecules27196264.
9
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.肿瘤抑制因子miR-637在癌症发生发展及预后中的功能失调与ceRNA网络
Biomark Res. 2022 Sep 30;10(1):72. doi: 10.1186/s40364-022-00419-8.
10
Is Autophagy Always a Barrier to Cisplatin Therapy?自噬是否始终是顺铂治疗的障碍?
Biomolecules. 2022 Mar 17;12(3):463. doi: 10.3390/biom12030463.